Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Bortezomib
.
Show all posts
Showing posts with label
Bortezomib
.
Show all posts
Thursday, December 15, 2011
Combination of bortezomib and panobinostat shows promise against advanced multiple myeloma
›
In co\continuation of my update on Bortezomib... A phase 2 clinical trial has shown that pairing bortezomib with an experimental drug,...
Thursday, July 22, 2010
Proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses - a new hope for autoimmune and inflammatory diseases?
›
In continuation of my update on Bortezomib , I found this info interesting to share with.. Japanese scientists lead by Dr. Koichi ...
2 comments:
Tuesday, December 22, 2009
New three-drug combination for multiple myeloma ! ...
›
The regimen, known as RVD , combined the drugs Revlimid - ( lenalidomide ), Velcade - ( bortezomib ) and dexamethasone , which previously we...
Friday, December 11, 2009
Carfilzomib for multiple myeloma ?
›
The proteasome has emerged as an important target for cancer therapy with the approval of bortezomib , a first-in-class, reversible prote...
Friday, November 6, 2009
Bortezomib for bone cancer in children & teens..
›
We knew that Bortezomib marketed as Velcade by Millennium Pharmaceuticals is the first therapeutic proteasome inhibitor to be tested in...
1 comment:
›
Home
View web version